Trial Profile
A Pharmacoepidemiological Study to Examine Patient Characteristics, Drug Utilization Pattern and Crude Incidence Rates of Selected Outcomes in New Users of Ticagrelor, Clopidogrel and Prasugrel in National Swedish Registries
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Apr 2016
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
- Indications Thrombosis
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 23 Apr 2015 Planned number of patients changed from 6000 to 7200 as reported by ClinicalTrials.gov record.
- 23 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 17 Jul 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.